23750002-0.1mg

antibody from Novus Biologicals

Targeting: IGF2BP2 IMP-2

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

23750002-0.1mg

Provider

Novus Biologicals

Product name

Rabbit Polyclonal IMP2/IGF2BP2 Antibody

Antibody type

Polyclonal

Description

Immunogen affinity purified. This product is specific for Human IGF2BP2.

Reactivity

Human

Host

Rabbit

Isotype

IgG

Vial size

0.1 mg

Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Western blot

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Western Blot: IMP2/IGF2BP2 Antibody [23750002] - Samples: Lane 1, Marker [kDa]: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil Target weight [kDa]: 66, 62 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.

ELISA

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

ELISA: IMP2/IGF2BP2 Antibody [23750002]

Immunohistochemistry

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Immunohistochemistry: IMP2/IGF2BP2 Antibody [23750002] - Both normal and malignant tissues showed moderate to strong cytoplasmic staining. In normal tissues, surface epithelial cells of bronchus, glandular cells of the intestine, endometrium and cervix, and trophoblastic cells displayed strong cytoplasmic staining. Pancreas, surface epithelial cells of oral mucosa, vagina and cervix, non-neuronal cells of CNS tissues and lymphoid tissues were negative. Colo-rectal, skin and testis carcinomas exhibited strong cytoplasmic staining while ovarian, stomach and pancreas malignancies displayed moderate to strong cytoplasmic staining. Malignant carcinoids showed weak cytoplasmic and nuclear staining. Renal and prostate malignancies were weak to negative. Image and statement courtesy of the Human Protein Atlas (HPA).